{"pmid":32381594,"title":"Call for ensuring cancer care continuity during COVID-19 pandemic.","text":["Call for ensuring cancer care continuity during COVID-19 pandemic.","ESMO Open","Tagliamento, Marco","Lambertini, Matteo","Genova, Carlo","Barisione, Emanuela","De Maria, Andrea","Grosso, Marco","Poggio, Francesca","Vagge, Stefano","Boccardo, Francesco","Pronzato, Paolo","Del Mastro, Lucia","32381594"],"journal":"ESMO Open","authors":["Tagliamento, Marco","Lambertini, Matteo","Genova, Carlo","Barisione, Emanuela","De Maria, Andrea","Grosso, Marco","Poggio, Francesca","Vagge, Stefano","Boccardo, Francesco","Pronzato, Paolo","Del Mastro, Lucia"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32381594","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1136/esmoopen-2020-000783","keywords":["covid-19","sars-cov-2","cancer","treatment"],"topics":["Prevention"],"weight":1,"_version_":1666267276751405056,"score":9.490897,"similar":[{"pmid":32415305,"title":"When cancer encounters COVID-19 in China: what have we suffered, experienced and learned.","text":["When cancer encounters COVID-19 in China: what have we suffered, experienced and learned.","The outbreak of the coronavirus disease (COVID-19) occurred in Wuhan, China, in December 2019. As of 21 March 2020, this epidemic has spread to 179 countries with more than 200 000 confirmed cases and 8578 deaths. The outbreak has put enormous pressure on the medical establishment and even led to exhaustion of medical resources in the most affected areas. Other medical work has been significantly affected in the context of COVID-19 epidemic. In order to reduce or avoid cross-infection with COVID-19, many hospitals have taken measures to limit the number of outpatient visits and inpatients. For example, emergency surgery can only be guaranteed, and most other surgeries can be postponed. Patients with cancer are one of the groups most affected by the epidemic because of their systematic immunosuppressive state and requirement of frequent admission to hospital. Consequently, specific adjustments for their treatment need to be made to cope with this situation. Therefore, it is of significance to summarize the relevant experience of China in the prevention and control of COVID-19 infection and treatment of patients with cancer during the epidemic.","Jpn J Clin Oncol","Chen, Haiyang","Wu, Xuan","Wang, Wei","Wang, Qiming","32415305"],"abstract":["The outbreak of the coronavirus disease (COVID-19) occurred in Wuhan, China, in December 2019. As of 21 March 2020, this epidemic has spread to 179 countries with more than 200 000 confirmed cases and 8578 deaths. The outbreak has put enormous pressure on the medical establishment and even led to exhaustion of medical resources in the most affected areas. Other medical work has been significantly affected in the context of COVID-19 epidemic. In order to reduce or avoid cross-infection with COVID-19, many hospitals have taken measures to limit the number of outpatient visits and inpatients. For example, emergency surgery can only be guaranteed, and most other surgeries can be postponed. Patients with cancer are one of the groups most affected by the epidemic because of their systematic immunosuppressive state and requirement of frequent admission to hospital. Consequently, specific adjustments for their treatment need to be made to cope with this situation. Therefore, it is of significance to summarize the relevant experience of China in the prevention and control of COVID-19 infection and treatment of patients with cancer during the epidemic."],"journal":"Jpn J Clin Oncol","authors":["Chen, Haiyang","Wu, Xuan","Wang, Wei","Wang, Qiming"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32415305","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1093/jjco/hyaa077","keywords":["covid-19","sars-cov-2","cancer","diagnosis","treatment"],"locations":["Wuhan","China","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666991242654777347,"score":63.474255},{"pmid":32500951,"title":"Singapore's experience in ensuring continuity of outpatient care during the COVID-19 pandemic.","text":["Singapore's experience in ensuring continuity of outpatient care during the COVID-19 pandemic.","The COVID-19 outbreak is a global pandemic with rapid community spread. Patients with multi-morbidities are particularly vulnerable during this time. The number of cases soared in early February 2020, and Singapore declared escalation of the Disease Outbreak Response System Condition (DORSCON) level to Orange. Multiple measures have been taken to combat the spread of this highly contagious infection. Despite our medical manpower being diverted to the wards, our hospital aims to maintain nearly full operations at the clinic, balancing against concern about the spread of the virus and exposing healthcare workers to potential risks. We describe the measures taken in a tertiary hospital in Singapore to mitigate the risk of infection in the outpatient setting while ensuring that continuing clinical care of patients with chronic diseases is not compromised.","Int J Clin Pract","Sek, Kathleen Sy","Tan, Andre Th","Yip, Alexander Wj","Boon, Eve Me","Teng, G G","Lee, Chun-Tsu","32500951"],"abstract":["The COVID-19 outbreak is a global pandemic with rapid community spread. Patients with multi-morbidities are particularly vulnerable during this time. The number of cases soared in early February 2020, and Singapore declared escalation of the Disease Outbreak Response System Condition (DORSCON) level to Orange. Multiple measures have been taken to combat the spread of this highly contagious infection. Despite our medical manpower being diverted to the wards, our hospital aims to maintain nearly full operations at the clinic, balancing against concern about the spread of the virus and exposing healthcare workers to potential risks. We describe the measures taken in a tertiary hospital in Singapore to mitigate the risk of infection in the outpatient setting while ensuring that continuing clinical care of patients with chronic diseases is not compromised."],"journal":"Int J Clin Pract","authors":["Sek, Kathleen Sy","Tan, Andre Th","Yip, Alexander Wj","Boon, Eve Me","Teng, G G","Lee, Chun-Tsu"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32500951","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/ijcp.13573","locations":["Singapore","Orange","Singapore","Singapore"],"countries":["Singapore","United States"],"countries_codes":["SGP|Singapore","USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1668890966432415744,"score":60.010033},{"pmid":32410776,"pmcid":"PMC7221367","title":"Clozapine treated patients and COVID-19: Ensuring continued care through collaboration.","text":["Clozapine treated patients and COVID-19: Ensuring continued care through collaboration.","Schizophr Res","Leung, Jonathan G","Wittenberger, Terri S","Schak, Kathryn M","32410776"],"journal":"Schizophr Res","authors":["Leung, Jonathan G","Wittenberger, Terri S","Schak, Kathryn M"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32410776","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.schres.2020.05.030","keywords":["covid-19","clozapine","pandemic","pharmacist","rems"],"e_drugs":["Clozapine"],"topics":["Prevention"],"weight":1,"_version_":1666897318954139649,"score":58.286545},{"pmid":32435648,"pmcid":"PMC7218121","title":"Coronavirus Disease 2019 Emergency and Cancer in the South of Italy: What's New for the Oncologist?","text":["Coronavirus Disease 2019 Emergency and Cancer in the South of Italy: What's New for the Oncologist?","Front Med (Lausanne)","Ingenito, Concetta","Buonerba, Luciana","Ferrara, Claudia","Busto, Giuseppina","Libroia, Annamaria","Ragone, Gianluca","Leo, Emilio","Savastano, Beatrice","Ioio, Concetta Dello","De Falco, Ferdinando","Iaccarino, Simona","Tarantino, Luciano","Polverino, Mario","Di Lorenzo, Giuseppe","32435648"],"journal":"Front Med (Lausanne)","authors":["Ingenito, Concetta","Buonerba, Luciana","Ferrara, Claudia","Busto, Giuseppina","Libroia, Annamaria","Ragone, Gianluca","Leo, Emilio","Savastano, Beatrice","Ioio, Concetta Dello","De Falco, Ferdinando","Iaccarino, Simona","Tarantino, Luciano","Polverino, Mario","Di Lorenzo, Giuseppe"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32435648","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3389/fmed.2020.00189","keywords":["cancer","coronavirus disease","management","patients","treatment"],"topics":["Prevention"],"weight":1,"_version_":1667521393658429442,"score":58.242485},{"pmid":32386875,"title":"Managing Cancer Care during the COVID-19 Pandemic and Beyond.","text":["Managing Cancer Care during the COVID-19 Pandemic and Beyond.","The coronavirus disease 2019 (COVID-19) pandemic is posing insurmountable challenges to healthcare systems globally. Cancer therapy is complex, and outcomes are centered on timing. Many oncology societies and health ministries have issued guidelines for cancer care to enable oncologists and patients to navigate the crisis. Lessons learned should inform care models for future pandemics.","Trends Cancer","Alhalabi, Omar","Subbiah, Vivek","32386875"],"abstract":["The coronavirus disease 2019 (COVID-19) pandemic is posing insurmountable challenges to healthcare systems globally. Cancer therapy is complex, and outcomes are centered on timing. Many oncology societies and health ministries have issued guidelines for cancer care to enable oncologists and patients to navigate the crisis. Lessons learned should inform care models for future pandemics."],"journal":"Trends Cancer","authors":["Alhalabi, Omar","Subbiah, Vivek"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32386875","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.trecan.2020.04.005","keywords":["covid-19","cancer","chemotherapy","immunotherapy","pandemic","research"],"topics":["Prevention"],"weight":1,"_version_":1666428892600074242,"score":50.868683}]}